WAT logo

Waters Corporation Stock Price

NYSE:WAT Community·US$19.5b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 19 Fair Values set on narratives written by author

WAT Share Price Performance

US$327.02
-78.27 (-19.31%)
US$394.68
Fair Value
US$327.02
-78.27 (-19.31%)
17.1% undervalued intrinsic discount
US$394.68
Fair Value
Price US$327.02
AnalystConsensusTarget US$394.68
AnalystLowTarget US$349.00
AnalystHighTarget US$480.00

WAT Community Narratives

AnalystConsensusTarget·
Fair Value US$394.68 17.1% undervalued intrinsic discount

Emerging Technologies And Share Repurchases Will Support Long-Term Market Opportunities

0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
AnalystLowTarget·
Fair Value US$349 6.3% undervalued intrinsic discount

Pharma Cost Pressures Will Erode Value But Foster Adaptation

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystHighTarget·
Fair Value US$480 31.9% undervalued intrinsic discount

LC-MS And Biotech Expansion Will Unlock Secular Healthcare Demand

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$349
6.3% undervalued intrinsic discount
Revenue
6.39% p.a.
Profit Margin
26.87%
Future PE
25.77x
Price in 2029
US$434.36
US$480
31.9% undervalued intrinsic discount
Revenue
7.58% p.a.
Profit Margin
26.58%
Future PE
34.61x
Price in 2029
US$596.73
US$394.68
17.1% undervalued intrinsic discount
Revenue
6.25% p.a.
Profit Margin
26.08%
Future PE
30.08x
Price in 2028
US$487.79

Trending Discussion

Updated Narratives

WAT logo

WAT: New Detector Launch And Higher Margins Will Likely Disappoint Optimists

Fair Value: US$349 6.3% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WAT logo

WAT: New Detector Launch And Stable Margins Will Support Future Upside

Fair Value: US$480 31.9% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WAT logo

WAT: Future Margin Gains And New Instruments Will Support Measured Earnings Outlook

Fair Value: US$394.68 17.1% undervalued intrinsic discount
11 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet and good value.

0 Risks
4 Rewards

Waters Corporation Key Details

US$3.2b

Revenue

US$1.3b

Cost of Revenue

US$1.9b

Gross Profit

US$1.2b

Other Expenses

US$642.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
10.79
59.28%
20.30%
55.0%
View Full Analysis

About WAT

Founded
1958
Employees
7900
CEO
Udit Batra
WebsiteView website
www.waters.com

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Recent WAT News & Updates

Recent updates

No updates